Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA
NCT02602704Phase 4Completed
- Sponsor
- Hanyang University
- Start
- Dec 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bazedoxifene in glucocorticoid-induced osteoporosis (GIOP), sponsored by Hanyang University. Started Dec 2015; status: completed.
02
Drugs
bazedoxifene
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT02602704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602704.